BioNTech SE
BNTX
$105.07
-$5.81-5.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 53.87% | -84.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 53.87% | -84.83% | |||
| Cost of Revenue | -1.68% | -66.02% | |||
| Gross Profit | 100.88% | -89.67% | |||
| SG&A Expenses | 22.87% | -9.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 48.12% | -218.20% | |||
| Total Operating Expenses | 11.08% | -35.19% | |||
| Operating Income | 4.74% | -407.94% | |||
| Income Before Tax | 2.49% | -245.99% | |||
| Income Tax Expenses | 41.34% | -170.08% | |||
| Earnings from Continuing Operations | -0.27% | -258.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.27% | -258.18% | |||
| EBIT | 4.74% | -407.94% | |||
| EBITDA | 7.89% | -260.20% | |||
| EPS Basic | 0.26% | -258.15% | |||
| Normalized Basic EPS | 3.01% | -225.16% | |||
| EPS Diluted | 0.26% | -258.52% | |||
| Normalized Diluted EPS | 3.01% | -225.16% | |||
| Average Basic Shares Outstanding | 0.53% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.53% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||